Riabov Vladimir, Yin Shuiping, Song Bin, Avdic Aida, Schledzewski Kai, Ovsiy Ilja, Gratchev Alexei, Llopis Verdiell Maria, Sticht Carsten, Schmuttermaier Christina, Schönhaber Hiltrud, Weiss Christel, Fields Alan P, Simon-Keller Katja, Pfister Frederick, Berlit Sebastian, Marx Alexander, Arnold Bernd, Goerdt Sergij, Kzhyshkowska Julia
Institute for Transfusion Medicine and Immunology, Medical Faculty Mannheim, Ruprecht-Karls University of Heidelberg, Mannheim, Germany.
Department of Dermatology, Medical Faculty Mannheim, Ruprecht-Karls University of Heidelberg, Mannheim, Germany.
Oncotarget. 2016 May 24;7(21):31097-110. doi: 10.18632/oncotarget.8857.
Stabilin-1 is a multifunctional scavenger receptor expressed on alternatively-activated macrophages. Stabilin-1 mediates phagocytosis of "unwanted-self" components, intracellular sorting, and endocytic clearance of extracellular ligands including SPARC that modulates breast cancer growth. The expression of stabilin-1 was found on tumor-associated macrophages (TAM) in mouse and human cancers including melanoma, lymphoma, glioblastoma, and pancreatic insulinoma. Despite its tumor-promoting role in mouse models of melanoma and lymphoma the expression and functional role of stabilin-1 in breast cancer was unknown. Here, we demonstrate that stabilin-1 is expressed on TAM in human breast cancer, and its expression is most pronounced on stage I disease. Using stabilin-1 knockout (ko) mice we show that stabilin-1 facilitates growth of mouse TS/A mammary adenocarcinoma. Endocytosis assay on stabilin-1 ko TAM demonstrated impaired clearance of stabilin-1 ligands including SPARC that was capable of inducing cell death in TS/A cells. Affymetrix microarray analysis on purified TAM and reporter assays in stabilin-1 expressing cell lines demonstrated no influence of stabilin-1 expression on intracellular signalling. Our results suggest stabilin-1 mediated silent clearance of extracellular tumor growth-inhibiting factors (e.g. SPARC) as a mechanism of stabilin-1 induced tumor growth. Silent clearance function of stabilin-1 makes it an attractive candidate for delivery of immunomodulatory anti-cancer therapeutic drugs to TAM.
稳定素-1是一种在交替激活的巨噬细胞上表达的多功能清道夫受体。稳定素-1介导“自身不需要的”成分的吞噬作用、细胞内分选以及包括调节乳腺癌生长的分泌性酸性富含半胱氨酸蛋白(SPARC)在内的细胞外配体的内吞清除。在小鼠和人类癌症(包括黑色素瘤、淋巴瘤、胶质母细胞瘤和胰腺胰岛素瘤)的肿瘤相关巨噬细胞(TAM)上发现了稳定素-1的表达。尽管其在黑色素瘤和淋巴瘤小鼠模型中具有促进肿瘤生长的作用,但稳定素-1在乳腺癌中的表达和功能作用尚不清楚。在此,我们证明稳定素-1在人类乳腺癌的TAM上表达,并且其表达在I期疾病中最为明显。使用稳定素-1基因敲除(ko)小鼠,我们发现稳定素-1促进小鼠TS/A乳腺腺癌的生长。对稳定素-1基因敲除的TAM进行的内吞作用分析表明,包括SPARC在内的稳定素-1配体的清除受损,而SPARC能够诱导TS/A细胞死亡。对纯化的TAM进行的Affymetrix微阵列分析以及在表达稳定素-1的细胞系中进行的报告基因分析表明,稳定素-1的表达对细胞内信号传导没有影响。我们的结果表明,稳定素-1介导的细胞外肿瘤生长抑制因子(如SPARC)的沉默清除是稳定素-1诱导肿瘤生长的一种机制。稳定素-1的沉默清除功能使其成为向TAM递送免疫调节抗癌治疗药物的有吸引力的候选者。